Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Pseudomonas aeruginosa MTB-1 - : Limosilactobacillus fermentum {L. fermentum} |
👶
Screening of Lactobacillus spp. for the prevention of Pseudomonas aeruginosa pulmonary infections. BMC microbiology (BMC Microbiol ) Vol: 14 Issue Pages: 107 Pub: 2014 Apr 27 Epub: 2014 Apr 27 Authors Alexandre Y , Le Berre R , Barbier G , Le Blay G , Html Article Publication |
| Decreases Pseudomonas aeruginosa MTB-1 - : Limosilactobacillus fermentum {L. fermentum} |
👶
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , Html Article Publication |
| Decreases Pseudomonas aeruginosa MTB-1 - : Limosilactobacillus fermentum {L. fermentum} |
👶
Identification of Antimicrobial Peptides from Novel Lactobacillus fermentum Strain. The protein journal (Protein J ) Vol: 39 Issue 1 Pages: 73-84 Pub: 2020 Feb Epub: Authors Pavlova AS , Ozhegov GD , Arapidi GP , Butenko IO , Fomin ES , Alemasov NA , Afonnikov DA , Yarullina DR , Ivanov VT , Govorun VM , Kayumov AR , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
